• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Grant Hugh

    4/2/25 4:38:46 PM ET
    $LIN
    Major Chemicals
    Industrials
    Get the next $LIN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    GRANT HUGH

    (Last) (First) (Middle)
    C/O LINDE PLC
    FORGE, 43 CHURCH STREET WEST

    (Street)
    WOKING SURREY X0 GU216HT

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    LINDE PLC [ LIN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Ordinary Shares 1,081.914 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units $0(1) (1) (1) Ordinary Shares 464 464 D
    Deferred Stock Units (2) 04/01/2025 A 72.791 (3) (3) Ordinary Shares 72.791 $0 219.9 D
    Explanation of Responses:
    1. The Restricted Stock Units ("RSU") shall vest in full one year after the March 7, 2025 date of grant, provided that the awardee serves on the Linde plc Board of Directors continuously through the vesting date, except under certain circumstances in which a pro-rata payout may be made. The awardee has deferred the payout of the RSU until termination of service as a director of Linde plc pursuant to the Linde Non-Employee Director Deferral Plan ("Plan"). The payout of the RSU will be in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
    2. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
    3. Deferred stock units ("DSU") acquired under the Linde Non-Employee Director Deferral Plan ("Plan"). The DSU will payout in Linde plc Ordinary Shares on a one-for-one basis upon termination of service as a director accordance with the Plan.
    Remarks:
    Anthony M. Pepper as attorney-in-fact 04/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LIN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LIN

    DatePrice TargetRatingAnalyst
    6/13/2025$576.00Outperform
    RBC Capital Mkts
    1/13/2025Hold → Buy
    TD Cowen
    4/18/2024$510.00Neutral → Buy
    Mizuho
    4/10/2024$475.00 → $500.00Buy → Neutral
    Citigroup
    3/27/2024$482.00 → $510.00Buy → Neutral
    UBS
    3/1/2024Peer Perform
    Wolfe Research
    2/16/2024$395.00 → $455.00Market Perform
    TD Cowen
    1/22/2024$429.00Buy → Hold
    Stifel
    More analyst ratings

    $LIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive VP, North America Durbin Sean exercised 7,795 units of Ordinary Shares at a strike of $176.63, covered exercise/tax liability with 5,171 units of Ordinary Shares and sold $3,314,272 worth of Ordinary Shares (7,261 units at $456.42), decreasing direct ownership by 36% to 8,151 units (SEC Form 4)

      4 - LINDE PLC (0001707925) (Issuer)

      5/27/25 4:31:40 PM ET
      $LIN
      Major Chemicals
      Industrials
    • New insider Innocenzi Stefanos claimed no ownership of stock in the company (SEC Form 3)

      3 - LINDE PLC (0001707925) (Issuer)

      5/20/25 4:15:39 PM ET
      $LIN
      Major Chemicals
      Industrials
    • Executive VP, Chief HR Officer Strauss David P sold $908,212 worth of Ordinary Shares (1,987 units at $457.04) (SEC Form 4)

      4 - LINDE PLC (0001707925) (Issuer)

      5/20/25 3:33:32 PM ET
      $LIN
      Major Chemicals
      Industrials